米国特許の有効性に異議を唱える ― 再審査
弊所の弁護士は、これまで数百の再審査を扱っており、これには、米国改正特許法(AIA)により当事者系再審査が当事者系レビューに置き換えられた以降扱った約100件が含まれます。AIAのもとでも、特有の法律と手続が適用される査定系再審査手続は、特許の有効性について争う際の重要なオプションの一つです。弊所は再審査の全ての手続的側面について経験があり、匿名で提出できる再審査を攻守の戦術として取り入れた訴訟戦略について定期的に助言しています。また、再審査、その他のAIA手続、並びに地裁及びITCの特許訴訟における第一人者として、弊所弁護士は、特許攻撃の総合的戦略の一部として再審査をどう活用するべきかについて、経験に基づいた確かな見識をもっています。
Represented DuPont in Federal Circuit appeal from Board decision in inter partes reexamination proceeding relating to transgenic soybean technology, leading to affirmance of the decision in DuPont’s favor.
17-1032, -1098, Fed. Cir.
2:06-cv-00334, E.D. Tex., Judges Folsom, Gilstrap
2:07-CV-02196, C.D. Cal., Judges Klausner, Mumm, Quinn
2:07-ml-01816, C.D. Cal., Judges Klausner, Mumm
CBM2015-00053, PTAB, Judges Busch, Cocks, Wormmeester
Ex Parte Reexamination No. 90/013,586, USPTO, Judge Ralis
2:15-cv-02329, W.D. Tenn., Judges McCalla, Pham
09-1450, -1451, -1452, -1468, -1469; 10-1017, Fed. Cir., Judges Bryson, Lourie, Newman
Member of team that represented Abbott Vascular in inter partes reexaminations related to biocompatible materials for medical devices.
Reexamination Nos. 95/000,552, 95/000,542, USPTO, Judge Jones
95/001,679, 95/001,746, 95/001,792, 95/001,851, 95/001,856, USPTO, Judges Foster, Hughes, Peikari, Pokrzywa
4:11-cv-05367, N.D. Cal., Judges Hamilton, Ryu
4:14-cv-04894, N.D. Cal., Judges Beeler, Hamilton, Seeborg
IPR2014-00833, PTAB, Judges Droesch, Lee, Zecher
16-1911, Fed. Cir., Judges Dyk, Hughes, O'Malley
95/001,682, 95/001,697, 95/001,714, 95/001,788, 95/001,789, 95/001,949, USPTO, Judges Bonshock, Foster, Peikari, Yigdall
Webinar
The Interplay between Inter Partes Review (IPR) Petition and Ex Parte Reexamination (XPR)
August 24, 2022
Webinar
At the PTAB Blog
May 25, 2021
Seminar
US Caselaw Update and Strategies for Amendment Practice (Plus Interactive Q&A)
November 17, 2020
Virtual
Justin A. Hendrix
The Legal 500 Says Finnegan Is “The Leading IP Boutique” for 2017 Rankings
June 2, 2017
James R. Barney
September 23, 2014
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.